3,4-Bis(phenylsulfonyl)-1,2,5-oxadiazole 2-Oxide - CAS 66074-00-8

Catalog:	BB032898
Product Name:	3,4-Bis(phenylsulfonyl)-1,2,5-oxadiazole 2-Oxide
CAS:	66074-00-8
Synonyms:	3,4-bis(benzenesulfonyl)-2-oxido-1,2,5-oxadiazol-2-ium; 3,4-bis(benzenesulfonyl)-2-oxido-1,2,5-oxadiazol-2-ium

Technical Data

Patents

Literatures

Computed Properties

IUPAC Name:	3,4-bis(benzenesulfonyl)-2-oxido-1,2,5-oxadiazol-2-ium
Description:	3,4-Bis(phenylsulfonyl)-1,2,5-oxadiazole 2-Oxide (CAS# 66074-00-8 ) is a useful research chemical.
Molecular Weight:	366.37
Molecular Formula:	C14H10N2O6S2
Canonical SMILES:	C1=CC=C(C=C1)S(=O)(=O)C2=NO[N+](=C2S(=O)(=O)C3=CC=CC=C3)[O-]
InChI:	InChI=1S/C14H10N2O6S2/c17-16-14(24(20,21)12-9-5-2-6-10-12)13(15-22-16)23(18,19)11-7-3-1-4-8-11/h1-10H
InChI Key:	PLIHJANRRMFJCC-UHFFFAOYSA-N
LogP:	3.93030

Publication Number	Title	Priority Date
CN-112390765-A	Multi-target antitumor retinoid derivative and synthesis method and application thereof	20201116
CN-108299415-A	A kind of quinoline quinone derivative and preparation method and purposes	20180131
CN-108299415-B	Quinolinequinone derivative and preparation method and application thereof	20180131
CN-107417678-A	Nitric oxide donator type dihydromyricetin derivative and its preparation and application	20170625
CN-107417678-B	Nitric oxide donor type dihydromyricetin derivative and preparation and application thereof	20170625

PMID	Publication Date	Title	Journal
20889239	20101201	Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity	European journal of medicinal chemistry
20684594	20100812	Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein	Journal of medicinal chemistry
18706821	20080901	Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies	Bioorganic & medicinal chemistry
15027876	20040325	Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents	Journal of medicinal chemistry

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Oxadiazole/Thiadiazole

[938459-06-4]
1-(5-Isopropyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
[1171337-26-0]
Ethyl 3-(1-(4-chloro-1H-pyrazol-1-yl)propan-2-yl)-1,2,4-oxadiazole-5-carboxylate
[1170042-55-3]
Ethyl 3-(1-(4-methyl-1H-pyrazol-1-yl)propan-2-yl)-1,2,4-oxadiazole-5-carboxylate
[1172750-87-6]
Ethyl 3-(2-(5-cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)ethyl)-1,2,4-oxadiazole-5-carboxylate
[1018125-37-5]
Ethyl 3-(2-fluorophenyl)-1,2,4-oxadiazole-5-carboxylate
[261626-93-1]
Ethyl 3-(2-thienyl)-1,2,4-oxadiazole-5-carboxylate

Complexity:	627
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	365.99802839
Formal Charge:	0
Heavy Atom Count:	24
Hydrogen Bond Acceptor Count:	7
Hydrogen Bond Donor Count:	0
Isotope Atom Count:	0
Monoisotopic Mass:	365.99802839
Rotatable Bond Count:	4
Topological Polar Surface Area:	137
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	2.2